Keyword: Biotechnology

News

Sanofi Seals two Oncology Partnerships

14.01.2016 - French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...

News

Industrial Biotech Firm Brain Plans IPO

07.01.2016 - In one of the rare stock launches of a German biotechnology company, industrial biotech firm Brain has announced plans to raise a double-digit sum through an initial public...

News

AstraZeneca Confirms Talks with Acerta

15.12.2015 - AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...

News

CDT to Commercialize Veterinary Cancer Drug

07.12.2015 - Spotlight Innovation, a venture capital-backed holding company specialized in identifying, acquiring and nurturing companies that have unique intellectual property in the medical...

News

Korean Drug Specialists Collaborate on Cancer Therapy

23.11.2015 - Singapore-based biotechnology firm Aslan Pharmaceuticals, which specializes in immunotherapy and targeted agents for cancer forms prevalent in Asia, has agreed to cooperate with...

News

DuPont to Buy Dyadic Biotech Assets

12.11.2015 - DuPont Industrial Biosciences is paying $75 million to acquire the enzyme and technology assets of Dyadic, a financially struggling US biotech firm based at Jupiter, Florida. The...

News

Shire to Buy Biotech Firm Dyax

04.11.2015 - Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...

Sites & Services

Quality and Reliability

28.10.2015 - The Swiss chemical industry has been dominated by worry and uncertainty in 2015. In 2011, the industry was severely affected by the downturn in the global economy and the...